Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD
Abstract Background Despite the effectiveness of methylphenidate for treating ADHD, up to 30% of individuals with ADHD show poor responses to methylphenidate. Neuroimaging biomarkers to predict medication responses remain elusive. This study characterized neuroanatomical features that differentiated...
Main Authors: | Jung-Chi Chang, Hsiang-Yuan Lin, Junglei Lv, Wen-Yih Issac Tseng, Susan Shur-Fen Gau |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-021-03040-5 |
Similar Items
-
ADHD, Methylphenidate, and Childhood Epilepsy
by: Rahul Sharma, et al.
Published: (2016-08-01) -
Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD
by: Wei-Chen Chuang, et al.
Published: (2019-06-01) -
Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01) -
Alopecia associated with use of methylphenidate: A case series
by: Sundar Gnanavel, et al.
Published: (2018-01-01) -
Methylphenidate does not restore the reduced serum BDNF levels in ADHD children
by: María-del-Carmen Augustin-Morales, et al.
Published: (2012-09-01)